Qiagen NV | QIA - Cost Of Sales

Stock Price
29.04
Daily Change
0.53 1.84%
Monthly
-16.43%
Yearly
-23.40%
Q2 Forecast
31.88

Qiagen NV reported $217.43M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
argenx SE USD 149.69M 40.26M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.24B 518M Dec/2025
Moderna USD 452M 245M Dec/2025
Organon & Co USD 766M 21M Dec/2025
Qiagen NV USD 217.43M 29.65M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025